Literature DB >> 36227588

10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study.

Isabela Campeti Cuoghi1, Mariana Furlani da Silva Soares1, Gustavo Motta Cabello Dos Santos2, Francisco José Candido Dos-Reis2, Omero Benedicto Poli-Neto2,3, Jurandyr Moreira de Andrade2, Priscila Longhin Bosquesi1,4, Leonardo Fleury Orlandini2, Daniel Guimarães Tiezzi1,2,3.   

Abstract

Background: Mammographic screening has been used to reduce breast cancer mortality worldwide and remains the main modality for the early detection of this disease. Women from low- and middle-income countries still lack access to periodic mammograms and efficient health care. This cross-sectional study aimed to explore opportunistic mammographic coverage in Brazil, while considering the privately insured population and its association with early breast cancer (EBC) detection.
Methods: Data on population, gross domestic product (GDP), number of mammograms performed under the Sistema Único de Saúde (SUS) public health system or private system, and women diagnosed with early-stage breast cancer from 2010 to 2019 were retrieved from publicly available databases.
Results: A total of 39 555 636 mammograms with an average of 3 955 564 ± 395 704 mammograms were obtained per year from 2010 to 2019 in Brazil. Most examinations (58.6%) were performed in the target population (50-69 years old), while 32% were performed in women aged 40-49, and 9.4% were performed in women <40 years or >70 years of age. The 10-year mammogram coverage was 30.6% in the target population and 24.8% in the population aged 40-49 years, with significant variation across states and municipalities. The overall EBC detection rates in Brazil were 30.6% in populations aged 50-70 and 24.8% in those aged 40-50 years. We observed a positive correlation between coverage and EBC detection rate (r = 0.68; P = 0.0001 (50-70 years) and r = 0.75; P < 0.0001 (40-50 years)). According to the GDP, the municipalities with higher GDP per capita had higher mammogram coverage (P < 0.0001). Conclusions: The coverage of mammographic screening for women under the SUS is far below the international guidelines. Additionally, a significant number of mammograms have been performed in non-target populations. This scenario reflects the problematic screening programs in developing countries and reflects low rates of EBC diagnosis. As Brazil is a continental country with heterogeneous socioeconomic indicators, we observed significant variations in the number of mammograms performed by age groups when separated by states and municipalities. Even when considering supplemental health system coverage, municipalities with higher GDP per capita were associated with higher mammogram coverage.
Copyright © 2022 by the Journal of Global Health. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 36227588      PMCID: PMC9564571          DOI: 10.7189/jogh.12.04061

Source DB:  PubMed          Journal:  J Glob Health        ISSN: 2047-2978            Impact factor:   7.664


  21 in total

1.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

2.  International statistical classification of diseases and related health problems. Tenth revision.

Authors:  G R Brämer
Journal:  World Health Stat Q       Date:  1988

3.  The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).

Authors:  Daniela Dornelles Rosa; José Bines; Gustavo Werutsky; Carlos Henrique Barrios; Eduardo Cronemberger; Geraldo Silva Queiroz; Vladmir C Cordeiro de Lima; Ruffo Freitas-Júnior; José d'Oliveira Couto; Karla Emerenciano; Heloísa Resende; Susane Crocamo; Tomás Reinert; Brigitte Van Eyil; Yeni Nerón; Vanessa Dybal; Nicolas Lazaretti; Rita de Cassia Costamilan; Diocésio Alves Pinto de Andrade; Clarissa Mathias; Giovana Zerwes Vacaro; Giuliano Borges; Alessandra Morelle; Maira Caleffi; Carlos Sampaio Filho; Max S Mano; Facundo Zaffaroni; Rafaela Gomes de Jesus; Sergio Daniel Simon
Journal:  Breast Cancer Res Treat       Date:  2020-07-29       Impact factor: 4.872

4.  Determinants of advanced stage presentation of breast cancer in 87,969 Brazilian women.

Authors:  Karen de Souza Abrahão; Anke Bergmann; Suzana Sales de Aguiar; Luiz Claudio Santos Thuler
Journal:  Maturitas       Date:  2015-08-29       Impact factor: 4.342

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs.

Authors:  László Tabár; Amy Ming-Fang Yen; Wendy Yi-Ying Wu; Sam Li-Sheng Chen; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; May Mei-Sheng Ku; Robert A Smith; Stephen W Duffy; Tony Hsiu-Hsi Chen
Journal:  Breast J       Date:  2014-11-20       Impact factor: 2.431

Review 7.  Breast cancer.

Authors:  Nadia Harbeck; Frédérique Penault-Llorca; Javier Cortes; Michael Gnant; Nehmat Houssami; Philip Poortmans; Kathryn Ruddy; Janice Tsang; Fatima Cardoso
Journal:  Nat Rev Dis Primers       Date:  2019-09-23       Impact factor: 52.329

8.  Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging.

Authors:  Debra L Monticciolo; Sharp F Malak; Sarah M Friedewald; Peter R Eby; Mary S Newell; Linda Moy; Stamatia Destounis; Jessica W T Leung; R Edward Hendrick; Dana Smetherman
Journal:  J Am Coll Radiol       Date:  2021-06-19       Impact factor: 5.532

9.  Breast cancer screening: updated recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations.

Authors:  Linei Augusta Brolini Dellê Urban; Luciano Fernandes Chala; Selma di Pace Bauab; Marcela Brisighelli Schaefer; Radiá Pereira Dos Santos; Norma Medicis de Albuquerque Maranhão; Ana Lucia Kefalas; José Michel Kalaf; Carlos Alberto Pecci Ferreira; Ellyete de Oliveira Canella; João Emílio Peixoto; Heverton Leal Ernesto de Amorim; Helio Sebastião Amâncio de Camargo Junior
Journal:  Radiol Bras       Date:  2017 Jul-Aug

10.  Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade.

Authors:  L Ding; S Jidkova; M J W Greuter; K Van Herck; M Goossens; P Martens; G H de Bock; G Van Hal
Journal:  Int J Equity Health       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.